Tacrolimus Market Size, Share & Growth Statistics Report to 2030

Tacrolimus Market Size, Share, Growth Trends, Industry Analysis and Forecast to 2030

Report ID: RC30978 | Report Format: PDF + Excel | Last Updated: September 3rd, 2025

The global tacrolimus market size was valued at around USD 7 billion in 2024 and expected to grow at a significant CAGR of over 5% during the forecast period from 2025 to 2030. The increasing number of organ transplants around the globe is a primary factor to drive the market growth. According to the latest information shared by HRSA, approximately 39,000 transplants were performed in 2020 in the USA, and in every 9 minutes, a person is added to the waiting list for the organ transplants. Furthermore, the growing prescription of tacrolimus to treat eczema and psoriasis around the world is another factor to fuel the market growth over the forecast period.

Report Attributes:

Benchmark Year		2024
Market Size		~ USD 7 Billion in 2024
Market Growth (CAGR)		> 5% (2025-2030)
Largest Market Share
Analysis Period		2020-2030
Market Players		Astellas Pharma, Inc, Mylan Pharmaceutical Industries Limited, GlaxoSmithKline, Plc, Glenmark Pharmaceuticals Ltd, and Teva Pharmaceutical Industries Limited

Tacrolimus Market Drivers:

The tacrolimus market is primarily driven by the increasing prevalence of organ transplants and autoimmune disorders worldwide. Tacrolimus, a potent immunosuppressant, is widely prescribed to prevent organ rejection in kidney, liver, and heart transplant patients. With the growing number of organ transplant procedures, particularly in North America and Europe, the demand for effective immunosuppressive therapy continues to rise. Additionally, the increasing incidence of autoimmune diseases such as atopic dermatitis, rheumatoid arthritis, and inflammatory bowel disease is contributing to the expanded use of topical and systemic formulations of tacrolimus, further fueling market growth.

Another key driver is the advancement in drug delivery systems and generic formulations, which has improved the accessibility and affordability of tacrolimus therapy. The availability of oral, topical, and extended-release formulations enables better patient compliance and targeted treatment, enhancing therapeutic outcomes. Rising awareness among healthcare professionals and patients about the benefits of early and continuous immunosuppressive therapy is also driving adoption. Furthermore, supportive government policies, reimbursement schemes, and increasing investment in healthcare infrastructure, especially in emerging markets, are strengthening the demand for tacrolimus globally.

Industry Trends Shaping the Tacrolimus Market:

The tacrolimus market is witnessing a trend toward the increasing adoption of generic formulations as patents for branded products expire. Generics offer more affordable treatment options without compromising efficacy, making immunosuppressive therapy accessible to a wider patient base, particularly in cost-sensitive markets. This trend is especially prominent in emerging economies, where rising organ transplant procedures and autoimmune disease prevalence are driving demand for lower-cost alternatives. Additionally, the growth of specialty pharmacies and online distribution channels is improving the availability and convenience of tacrolimus therapy for patients worldwide.

Another key trend is the expansion of tacrolimus applications beyond organ transplantation, particularly in dermatology. Topical tacrolimus ointments are increasingly used to manage moderate to severe atopic dermatitis and other inflammatory skin conditions, providing an alternative to corticosteroids. Advances in formulation technology, including extended-release and targeted delivery systems, are enhancing therapeutic outcomes and reducing side effects. Furthermore, ongoing clinical research exploring tacrolimus for additional autoimmune and inflammatory disorders is opening new opportunities, positioning it as a versatile immunosuppressive agent across multiple therapeutic areas.

Tacrolimus Market Opportunities:

The tacrolimus market offers significant opportunities in the expansion of organ transplant procedures and related immunosuppressive therapy, particularly in emerging economies. With rising incidences of end-stage organ failures and increasing access to advanced healthcare infrastructure, the demand for effective immunosuppressants like tacrolimus is expected to grow. Companies can capitalize on this trend by introducing affordable generic formulations and developing patient support programs that improve adherence and outcomes, especially in regions where treatment costs remain a barrier.

Another promising opportunity lies in the diversification of tacrolimus applications beyond transplantation, particularly in dermatology and autoimmune disorders. Topical tacrolimus formulations are gaining popularity for managing atopic dermatitis and other chronic inflammatory skin conditions, providing alternatives to corticosteroids. Ongoing research into its potential use in additional autoimmune diseases, along with the development of novel delivery systems such as sustained-release formulations and combination therapies, creates avenues for expanding market penetration. Additionally, strategic partnerships with healthcare providers, specialty pharmacies, and digital health platforms can enhance accessibility and patient engagement, strengthening long-term growth prospects.

Market Segment Insights:

The global tacrolimus market is bifurcated into clinical application, distribution channel, and geography. On the basis of clinical application, the market is further segmented into immunosuppressant, dermatology, and others. The immunosuppressant segment is accounted to hold the largest market share in 2020. The segment growth is attributed to the increasing number of organ transplants across the globe. According to the latest information shared by the World Health Organization (WHO), around 100,800 solid organ transplants performed every year across the globe. Furthermore, the increasing incidence of autoimmune diseases is further supporting the market growth over the forecast period.

Moreover, the dermatology segment is expected to grow at a significant growth rate over the forecast period due to the increasing incidence of skin complications globally. According to the latest information shared by National Psoriasis Foundation (NPF), around 125 million people are suffering from psoriasis across the globe. As per the European Society for Medical Oncology (ESMO), 1% to 3% population is affected by eczema around the world.

The tacrolimus comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Tacrolimus Market Segmentation:

By Clinical Application:

Immunosuppressant
Dermatology
Others

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage:

Geographically, the tacrolimus market report comprises dedicated sections centering on the regional market revenue and trends. The market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. The market estimates have also been provided for the historical years along with forecasts for the period from 2025 – 2030.

Tacrolimus Market Competition Assessment:

Key players operating in the global tacrolimus market are Astellas Pharma, Inc, Mylan Pharmaceutical Industries Limited, GlaxoSmithKline, Plc, Glenmark Pharmaceuticals Ltd, and Teva Pharmaceutical Industries Limited. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Astellas Pharma, Inc
Mylan Pharmaceutical Industries Limited
GlaxoSmithKline, Plc
Glenmark Pharmaceuticals Ltd
Teva Pharmaceutical Industries Limited
Hoffman La-Roche
Reddy’s Laboratories Ltd.
Sandoz, Inc.
Chiesi Farmaceutici.
Abbott Laboratories, Inc.

Key Questions Answered by Tacrolimus Market Report:

Global tacrolimus market forecasts from 2021-2027
Regional tacrolimus market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Tacrolimus submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Tacrolimus Market Portraiture
2.2. Global Tacrolimus Market, by Clinical Distribution Channel, 2020 (USD Mn)
2.3. Global Tacrolimus Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Tacrolimus Market, by Geography, 2020 (USD Mn)

3. Global Tacrolimus Market Analysis

3.1. Tacrolimus Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

4. Global Tacrolimus Market By Clinical Distribution Channel, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Immunosuppressant
4.3. Dermatology
4.4. Others

5. Global Tacrolimus Market By Distribution Channel, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

6. North America Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

6.1.1. Overview
6.1.2. North America Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
6.1.3. North America Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Tacrolimus Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.2. Canada

7. Europe Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

7.1.1. Overview
7.1.2. Europe Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
7.1.3. Europe Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Tacrolimus Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.2. U.K.
7.1.4.3. France
7.1.4.4. Italy
7.1.4.5. Rest of Europe

8. Asia Pacific Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

8.1.1. Overview
8.1.2. Asia Pacific Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
8.1.3. Asia Pacific Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Tacrolimus Market by Country (2018-2027 USD Mn)
8.1.4.1. China.
8.1.4.2. Japan
8.1.4.3. Rest of Asia Pacific

9. Latin America (LATAM) Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

9.1.1. Overview
9.1.2. Latin America Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
9.1.3. Latin America Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Tacrolimus Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.4.3. Rest of Latin America

10. Middle East and Africa Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

10.1.1. Overview
10.1.2. MEA Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
10.1.3. MEA Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Tacrolimus Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.2. Rest of MEA

11. Company Profiles

11.1. Astellas Pharma, Inc.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Mylan Pharmaceutical Industries Limited
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. GlaxoSmithKline, Plc
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Glenmark Pharmaceuticals Ltd
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Teva Pharmaceutical Industries Limited
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. F.Hoffman La-Roche
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Dr. Reddy’s Laboratories Ltd.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Sandoz, Inc.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Chiesi Farmaceutici.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Abbott Laboratories, Inc.
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis

To know more about the study, request sample papers

List of Tables:

TABLE 1 Market Snapshot: Global Tacrolimus Market

TABLE 2 Impact Indicators

TABLE 3 Impact Analysis of Drivers and Challenges

TABLE 4 Global Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 5 Global Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 6 North America Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 7 North America Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 8 North America Tacrolimus Market Value, By Country, 2018 - 2027 (US$ Mn)

TABLE 9 U.S. Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 10 U.S. Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 11 Canada Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 12 Canada Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 13 Europe Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 14 Europe Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 15 Europe Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 16 Germany Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 17 Germany Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 18 U.K. Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 19 U.K. Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 20 France Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 21 France Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 22 Italy Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 23 Italy Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 24 Rest of Europe Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 25 Rest of Europe Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 26 Asia Pacific Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 27 Asia Pacific Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 28 Asia Pacific Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 29 Japan Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 30 Japan Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 31 China Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 32 China Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 33 Rest of Asia Pacific Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 34 Rest of Asia Pacific Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 35 Latin America Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 36 Latin America Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 37 Latin America Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 38 Brazil Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 39 Brazil Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 40 Mexico Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 41 Mexico Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 42 Rest of Latin America Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 43 Rest of Latin America Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 44 Middle East & Africa Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 45 Middle East & Africa Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 46 Middle East & Africa Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 47 GCC Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 48 GCC Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 49 Rest of MEA Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 50 Rest of MEA Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 51 Astellas Pharma, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 52 Mylan Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 53 GlaxoSmithKline, Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 54 Glenmark Pharmaceuticals Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 55 Teva Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 56 F.Hoffman La-Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 57 Dr. Reddy’s Laboratories Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 58 Sandoz, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 59 Chiesi Farmaceutici.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 60 Abbott Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

To know more about the study, request sample papers

List of Figures:

FIG. 1 Global Tacrolimus: Market Segmentation

FIG. 2 Global Tacrolimus Market: Research Methodology

FIG. 3 Top-Down and Bottom-up Approach

FIG. 4 Global Tacrolimus Market, by Clinical Application, 2019 (US$ Mn)

FIG. 5 Global Tacrolimus Market, by Distribution Channel, 2019 (US$ Mn)

FIG. 6 Global Tacrolimus Market, by Geography, 2019 (US$ Mn)

FIG. 7 Global Tacrolimus Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)

FIG. 8 Attractive Investment Proposition, by Geography, 2017

FIG. 9 Market Positioning of Key Tacrolimus Providers, 2019

FIG. 10 Global Tacrolimus Market Value Share, by Clinical Application, 2018 & 2027 (%)

FIG. 11 Global Tacrolimus Market Value for Immunosuppressant, 2018 - 2027, (US$ Mn)

FIG. 12 Global Tacrolimus Market Value for Dermatology, 2018 - 2027, (US$ Mn)

FIG. 13 Global Tacrolimus Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 14 Global Tacrolimus Market Value Share, by Distribution Channel, 2018 & 2027 (Value %)

FIG. 15 Global Tacrolimus Market Value for Hospital Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 16 Global Tacrolimus Market Value for Retail Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 17 Global Tacrolimus Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 18 North America Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 19 Europe Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 20 Asia Pacific Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 21 LATIN America Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 22 Middle East & Africa Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

Fill the given form to inquiry before buying for Tacrolimus Market Report

Download Sample Papers

Inquiry Before Buying

Schedule a Call

Select License Type

$ 4250/- Single User License
$ 5200/- Multi User License
$ 6950/- Corporate License